SARS-CoV-2 pneumonia and Eisenmenger’s syndrome: doubling the challenge

Submitted: August 5, 2023
Accepted: October 23, 2023
Published: November 6, 2023
Abstract Views: 611
PDF: 18
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Eisenmenger’s syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension secondary to congenital heart disease. In these cases, significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease and pulmonary hypertension. In cases of acute hypoxemic respiratory failure in patients with ES, high-flow nasal cannula (HFNC) oxygen therapy should be considered as a first-line approach in order to avoid pulmonary complications and right ventricular overload related to positive pressure ventilation. Here, we report a case of HFNC use in a patient with COVID-19 infection and ES.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Nashat H, Kempny A, McCabe C, et al. Eisenmenger syndrome: current perspectives. Res Rep Clinl Cardiol 2017;8:1-12.
Buonamico E, Quaranta VN, Boniello E, et al. Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19. Respir Investig 2021;59:602-7.
Ippolito M, Simone B, Filisina C, et al. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms 2021;9:2016.
Crimi C, Noto A, Cortegiani A, et al. Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections. Minerva Anestesiol 2020;86:1190-204.
Racca F, Appendini L, Berta G, et al. Helmet ventilation for acute respiratory failure and nasal skin breakdown in neuromuscular disorders. Anesth Analg 2009;109:164-7.
Pierucci P, Ambrosino N, Di Lecce V, et al. Prolonged active prone positioning in spontaneously breathing non-intubated patients with COVID-19-associated hypoxemic acute respiratory failure with PaO2/FiO2>150. Front Med (Lausanne) 2021;8:626321.
Vega ML, Dongilli R Olaizola G, et al. COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Pulmonology 2022;28:13-7.
Carpagnano GE, Pierucci P, Migliore G, et al. Tailored post-acute care coordination for survivors of moderate to severe COVID-19 infection. J Am Med Dir Assoc 2022;23:447-9.
Walker F, Mullen MJ, Woods SJ, Webb GD. Acute effects of 40% oxygen supplementation in adults with cyanotic congenital heart disease. Heart 2004;901073-4.
Pierucci P, Portacci A, Carpagnano GE, et al. The right interface for the right patient in noninvasive ventilation: a systematic review. Expert Rev Respir Med 2022;16:931-44.
Oczkowski S, Ergan B, Bos L, et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J 2022;59:2101574.
Misseri G, Pierucci P, Bellina D, et al. Early pronation, protective lung ventilation and use of awake-prone-HFNO therapy after extubation in near-fatal drowning. Pulmonology 2024;30:198-201.

How to Cite

Pierucci, Paola, Lucrezia De Michele, Maria Luisa de Candia, Federica Barratta, Cesare Gregoretti, Giovanna Elisiana Carpagnano, and Giovanni Misseri. 2023. “SARS-CoV-2 Pneumonia and Eisenmenger’s Syndrome: Doubling the Challenge”. Monaldi Archives for Chest Disease 94 (4). https://doi.org/10.4081/monaldi.2023.2741.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.